Korea’s drug safety ministry released its comprehensive annual medical product approval reports in English, Friday, in a move aimed at enhancing regulatory transparency and bolstering the international credibility of the country’s booming health care sector. The Ministry of Food and Drug Safety said the newly translated reports cover pharmaceuticals, quasi-drugs and medical devices approved throughout 2025. By providing granular data to global audiences, the ministry said it hopes to strengthen the competitive edge of Korean medical products. The English-language publications follow a domestic Korean release in April. They arrive as Korea seeks to deeply integrate its pharmaceutical and biotechnology industries into global supply chains, requiring closer alignment with international regulatory reporting standards. “Expanding the disclosure of transparent approval information is critical to raising global trust in our medical products,” a ministry spokesperson said. Available on the agency's official English website, the reports offer a deep dive into Korea's regulatory landscape